Arsenic trioxide (As2O3) induces differentiation and apoptosis of acute promyelocytic leukemia (APL) cells by binding to the PML-RARα oncoprotein[27], and treatment with As2O3 has been shown to increase remission rates and prolong survival in patients[28]. Here, PML is linked to acute promyelocytic leukemia.